Descriptor English: | Pertussis Vaccine | ||||||
Descriptor Spanish: |
Vacuna contra la Tos Ferina
| ||||||
Descriptor Portuguese: | Vacina contra Coqueluche | ||||||
Descriptor French: | Vaccin anticoquelucheux | ||||||
Entry term(s): |
Vaccine, Pertussis |
||||||
Tree number(s): |
D20.215.894.135.535 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010567 | ||||||
Scope note: | A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) |
||||||
Annotation: | DIPHTHERIA-TETANUS-PERTUSSIS VACCINE is also available |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Related: |
Whooping Cough
MeSH | ||||||
DeCS ID: | 23136 | ||||||
Unique ID: | D010567 | ||||||
NLM Classification: | WC 340 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2010/06/25 |
-
-
CHEMICALS AND DRUGS
Complex Mixtures [D20]Complex Mixtures
|
Pertussis Vaccine
- Preferred
Concept UI |
M0016424 |
Scope note | A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) |
Preferred term | Pertussis Vaccine |
Entry term(s) |
Vaccine, Pertussis |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey